Difference between revisions of "Minutes - Medication WG 2022-09-27"
From Health Level 7 Belgium Wiki
KarlienErauw (talk | contribs) |
KarlienErauw (talk | contribs) |
||
Line 40: | Line 40: | ||
* are there FHIR SAM specifications ? | * are there FHIR SAM specifications ? | ||
* medication scheme will have a generic data structure driven by the business rules | * medication scheme will have a generic data structure driven by the business rules | ||
+ | ::* are the business rules mature enough to start an implementation ? probably not | ||
+ | ::* compatibility with kmehr is necessary | ||
+ | ::* this needs to be discussed in the next meetings | ||
+ | * evolutions in other European countries (f.e. Switserland) | ||
'''Agenda items for next meeting''' | '''Agenda items for next meeting''' | ||
− | * presentation by Sam of how FHIR has been used in their medication scheme | + | * presentation by Sam of how FHIR has been used in their medication scheme |
+ | |||
'''Next meeting Oct 18 at 11AM - TBC''' | '''Next meeting Oct 18 at 11AM - TBC''' |
Revision as of 09:37, 27 September 2022
Attendees
- Annemieke Vergauwe
- Anne Nerenhausen
- Jan Lenie
- Jens Penny
- Jean-Michel Polfliet
- José Costa Teixeira
- Karlien Erauw
- Marc Buckens
- Pablo Christiaens
- Richard Francken
- Sam Goudsmit (Zorgi)
- Thomas Van Langendonck
- Tom Henkens
- Walter Bollaert
Excused/Not present
- Bart Decuypere
- Bruno Casneuf
- Dieter Sauvillers
- Elhassan Baazizi
- Hanne Vuegen
- Jean-Louis Maggetto
- Katrien Thorré
- Lars Vanreppelen
- Nick Hermans
- Nils Devos
- Tom De Backer
- Will van Norel
Agenda
- Current state of profiles on medication view and treatment lines and how it all works at operational level
- Review glossary of terms &
- Collect feedback on contraindications
- Identifying business rules
Minutes
- Sam asks how these efforts fit in the VIDIS project
- does a Kmehr datamodel for medication scheme exist ? Marc will send functional models to José, also see here: https://www.vitalink.be/voor-ontwikkelaars/technische-documentatie
- are there FHIR SAM specifications ?
- medication scheme will have a generic data structure driven by the business rules
- are the business rules mature enough to start an implementation ? probably not
- compatibility with kmehr is necessary
- this needs to be discussed in the next meetings
- evolutions in other European countries (f.e. Switserland)
Agenda items for next meeting
- presentation by Sam of how FHIR has been used in their medication scheme
Next meeting Oct 18 at 11AM - TBC